Developmental motor deficits induced by combined fetal exposure to lipopolysaccharide and early neonatal hypoxia/ischemia: A novel animal model for cerebral palsy in very premature infants

A critical issue in animal models of perinatal brain injury is to adapt the pertinent pathophysiological scenarios to their corresponding developmental window in order to induce neuropathological and behavioral characteristics reminiscent to perinatal cerebral palsy (CP). A major problem in most of these animal models designed up to now is that they do not present motor deficits characteristic of CP. Using a unique rat paradigm of prenatal inflammation combined to an early postnatal hypoxia–ischemia pertinent to the context of very early premature human newborns, we were interested in finding out if such experimental conditions might reproduce both histological damages and behavioral deficits previously described in the human context. We showed that exposure to lipopolysaccharide (LPS) or hypoxia–ischemia (H/I) induced behavioral alterations in animals subjected to forced motor activity. When both LPS and H/I aggressions were combined, the motor deficits reached their highest intensity and affected both spontaneous and forced motor activities. LPS+H/I-exposed animals also showed extensive bilateral cortical and subcortical lesions of the motor networks affecting the frontal cortices and underlying white matters fascicles, lenticular nuclei and the substantia nigra. These neuropathological lesions and their associated motor behavioral deficits are reminiscent of those observed in very preterm human neonates affected by subsequent CP and validate the value of the present animal model to test new therapeutic strategies which might open horizons for perinatal neuroprotection.     

Risk of serious illness in heterozygotes for ornithine transcarbamylase deficiency

Ornithine transcarbamylase (OTC) deficiency is an X-linked disorder associated with hyperammonemia. Heterozygous females have variable clinical expression, ranging from asymptomatic illness to recurrent episodes of hyperammonemic coma. We studied 17 OTC-deficient kindreds containing 114 women at risk for heterozygosity. Sixty-one of these women were designated heterozygotes by pedigree analysis, history of protein intolerance, protein tolerance tests, or DNA probe studies. Eleven (18%) of the 61 heterozygotes had experienced encephalopathic episodes; nine (82%) girls died during these episodes. Our findings indicate that there is a significant risk of symptomatic hyperammonemia in females heterozygous for OTC deficiency. We suggest that, within OTC-deficient kindreds, females at risk should be identified early, by means of protein tolerance tests and DNA probe studies. Those who develop significant hyperammonemia after a protein load should be considered for long-term alternate pathway therapy and should receive aggressive therapy during hyperammonemic episodes.     

Receptor-mediated internalization of [3H]-neurotensin in synaptosomal preparations from rat neostriatum

Following its binding to somatodendritic receptors, the neuropeptide neurotensin (NT) internalizes via a clathrin-mediated process. In the present study, we investigated whether NT also internalizes presynaptically using synaptosomes from rat neostriatum, a region in which NT1 receptors are virtually all presynaptic. Binding of [³H]–NT to striatal synaptosomes in the presence of levocabastine to block NT2 receptors is specific, saturable, and has NT1 binding properties. A significant fraction of the bound radioactivity is resistant to hypertonic acid wash indicating that it is internalized. Internalization of [³H]–NT, like that of [¹²⁵I]–transferrin, is blocked by sucrose and low temperature, consistent with endocytosis occurring via a clathrin-dependent pathway. However, contrary to what was reported at the somatodendritic level, neither [³H]–NT nor [¹²⁵I]–transferrin internalization in synaptosomes is sensitive to the endocytosis inhibitor phenylarsine oxide. Moreover, treatment of synaptosomes with monensin, which prevents internalized receptors from recycling to the plasma membrane, reduces [³H]–NT binding and internalization, suggesting that presynaptic NT1 receptors, in contrast to somatodendritic ones, are recycled back to the plasma membrane. Taken together, these results suggest that NT internalizes in nerve terminals via an endocytic pathway that is related to, but is mechanistically distinct from that responsible for NT internalization in nerve cell bodies.     

Serotonin nerve terminals in adult rat neocortex

Axonal processes which take up and retain exogenous tritiated serotonin ([³H]5-HT) have been demonstrated in the fronto-parietal cortex of adult rats, by means of high resolution radioautography. Prolonged topical superfusion with relatively high concentrations of [³H]5-HT allowed detection of a maximal number of axonal reactions in the upper 3 layers of cortex. Comparison of results obtained from normal rats and animals pretreated with 6-hydroxydopamine or bearing midbrain raphe lesions established the specificity of this labeling. All reactive axons seemed to arise from the serotonin nerve cell bodies in groups B7 and B8 of Dahlström and Fuxe¹⁵.

In electron microscope radioautographs, the serotonin fibers appeared as tenuous, naked axonal processes (0.1–0.5 μm in diameter) exhibiting small enlargements (0.7 μm in mean diameter) spaced at frequent intervals (1–3 μm). These boutons contained occasional mitochondria, small, round, agranular ‘synaptic’ vesicles and large granular vesicles.

Within axons, [³H]5-HT was concentrated in the boutons, and to a much lesser extent in connecting segments. This reactive pattern resembled that revealed by the fluorescence technique for endogenous serotonin. Preferential accumulations of the tracer by mitochondria and vesicular organelles indicated that these elements could sequester exogenous serotonin.

Large granular vesicles were not necessarily visible in random thin sections of the labeled varicosities, and thus could not serve as the unique criterion for electron microscopic identification of 5-HT terminals. Moreover, these organelles are known to be present in other types of nerve endings.

Topometric analysis of serial thin sections nevertheless demonstrated that large granular vesicles were potentially detectable in every 5-HT containing bouton, and also enabled extrapolation of their average number at 7 per varicosity. This low number makes it unlikely that large granular vesicles primarily represent storage sites. They could rather serve as a carrier for particle-bound enzymes essential to the local metabolism of serotonin or its precursors.

A very small fraction of the serotonin varicosities exhibited the membrane differentiations of typical synaptic terminals. Extensive sampling in serial thin sections revealed junctional complexes in only 5% of labeled boutons, as opposed to 50% of unlabeled nerve endings in the sorrounding neuropil. The data do not preclude the possibility that other monoaminergic neurons also share similar characteristics.

It is probable that endogenous serotonin can be liberated from all axonal varicosities including those lacking strictu senso synaptic relationships. The overall configuration and ultrastructural features of cortical serotonin fibers suggest intrinsic dynamic properties which could assume particular significance in terms of function, plasticity and regrowth.